Indrayani Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	45.59	2.88	5.82	30.37	15.03	6.79
Short-Term Investments	24.17	262.11	296.7	96.58	6.77	-
Cash & Short-Term Investments	69.77	265	302.52	126.94	21.8	6.79
Cash Growth	-	-12.40%	138.31%	482.33%	221.19%	-51.59%
Accounts Receivable	622.99	586.9	395.29	299.72	140.99	47.68
Other Receivables	-	405.58	245.41	177.15	12.83	14.57
Receivables	878.37	1,078	709.17	500.53	153.82	62.25
Inventory	432.14	413.42	423.51	122.14	15.32	10.9
Other Current Assets	458.96	22.84	14.56	25.62	4.97	11.58
Total Current Assets	1,839	1,779	1,450	775.23	195.91	91.52
Property, Plant & Equipment	619.49	600.04	593.77	478.56	259.38	252.52
Long-Term Investments	2.81	2.48	2.23	2.23	0.01	0.12
Goodwill	233.47	233.47	233.47	233.47	38.41	38.41
Other Intangible Assets	-	0.01	-	0.15	-	-
Long-Term Deferred Tax Assets	2.21	-0.49	3.32	0.38	-	-
Other Long-Term Assets	47.34	64.04	57.46	69.6	20.3	17.98
Total Assets	2,745	2,679	2,340	1,560	514.01	400.55
Accounts Payable	170.19	235.83	373.9	227.38	58.2	33.36
Accrued Expenses	-	61.43	55.3	54.82	22.03	10.89
Short-Term Debt	-	704.36	398.51	314.31	111.03	73.83
Current Portion of Long-Term Debt	453.86	12.22	12.16	19.44	-	-
Current Portion of Leases	-	-	7.93	11.25	3.57	-
Current Income Taxes Payable	-	8.21	6.19	2.01	-	-
Current Unearned Revenue	-	0.35	0.33	0.12	-	-
Other Current Liabilities	71.63	2.44	16.4	89.77	-	-
Total Current Liabilities	695.68	1,025	870.72	719.1	194.82	118.07
Long-Term Debt	1,009	654.15	665.97	293.7	67.85	81.54
Long-Term Leases	-1.35	-	40.67	63.16	5.5	-
Long-Term Deferred Tax Liabilities	2.76	-	-	0.14	0.14	0.14
Other Long-Term Liabilities	-	0.75	-	-	-	-
Total Liabilities	1,706	1,680	1,577	1,076	268.31	199.75
Common Stock	455.36	455.36	455.36	342.27	342.27	342.27
Additional Paid-In Capital	-	201.74	126.64	114.01	0.09	-
Retained Earnings	-	33.11	48.94	-13.36	-100.72	-145.12
Comprehensive Income & Other	582.81	34.88	41.18	15.44	-	0.05
Total Common Equity	1,038	725.1	672.12	458.37	241.63	197.2
Minority Interest	-	274.07	90.54	-67.34	4.06	3.6
Shareholders' Equity	1,038	999.16	762.66	483.53	245.7	200.8
Total Liabilities & Equity	2,745	2,679	2,340	1,560	514.01	400.55
Total Debt	1,462	1,371	1,125	701.86	187.94	155.36
Net Cash (Debt)	-1,392	-1,106	-822.72	-574.92	-166.15	-148.58
Net Cash Per Share	-	-24.28	-18.07	-13.22	-4.85	-4.17
Filing Date Shares Outstanding	-	45.54	45.54	34.23	34.23	34.23
Total Common Shares Outstanding	-	45.54	45.54	34.23	34.23	34.23
Working Capital	1,144	754.51	579.04	56.13	1.08	-26.55
Book Value Per Share	-	15.92	14.76	13.39	7.06	5.76
Tangible Book Value	804.7	491.61	438.65	224.75	203.22	158.79
Tangible Book Value Per Share	-	10.80	9.63	6.57	5.94	4.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.